Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer

Cancer Research

Volumn 64, Issue 22, 2004, Pages 8184-8192

  Leu, Yu Wei ^a   Yan, Pearlly S ^a   Fan, Meiyun ^b,c   Jin, Victor X ^a   Liu, Joseph C ^a   Curran, Edward M ^d   Welshons, Wade V ^d   Wei, Susan H ^a   Davuluri, Ramana V ^a   Plass, Christoph ^a   Nephew, Kenneth P ^b,c   Huang, Tim H M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ESTROGEN RECEPTOR; HISTONE DEACETYLASE; PROGESTERONE RECEPTOR; REPRESSOR PROTEIN; RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; DNA TRANSCRIPTION; EPIGENETICS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGENY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SILENCER ELEMENT; TARGET CELL;

BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA PRIMERS; EPIGENESIS, GENETIC; GENE SILENCING; HUMANS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 8544226964     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2045     Document Type: Article

References (48)

1. Schiff R, Massarweh S, Shou J, Osborne, CK. Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response. Clin Cancer Res 2003;9:447s-54s.
2. Jensen EV, Jordan VC. The estrogen receptor: a model for molecular medicine. Clin Cancer Res 2003;9:1980-9.
3. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002;16:6-21.
4. Ehrlich M. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells. Nucleic Acids Res 1982;10:2709-21.
5. Ehrlich M. Expression of various genes is controlled by DNA methylation during mammalian development. J Cell Biochem 2003;88:899-910.
6. Ballestar E, Esteller M. The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis (Lond) 2002;23:1103-9.
7. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-28.
8. Nephew KP, Huang TH-M. Epigenetic gene silencing in cancer initiation and progression. Cancer Lett 2003;190:125-33.
9. Baylin SB, Esteller M, Rountree MR, et al. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 2001;10:687-92.
10. Rountree MR, Bachman KE, Herman JG, Baylin SB. DNA methylation, chromatin inheritance, and cancer. Oncogene 2001;20:3156-65.
11. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004;4:143-53.
12. Jenuwein T, Allis CD. Translating the histone code. Science (Wash DC) 2001;293:1074-80.
13. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature (Lond) 1997;389:349-52.
14. Kouzarides T. Histone methylation in transcriptional control. Curr Opin Genet Dev 2002;12:198-209.
15. Tamaru H, Selker EU. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature (Lond) 2001;414:277-83.
16. Tamaru H, Zhang X, McMillen D, et al. Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa. Nat Genet 2003;12:177-85.
17. Eden S, Hashimshony T, Keshert I, Cedar H, Thorne AW. DNA methylation models histone acetylation. Nature (Lond) 1998;394:842.
18. Schubeler D, Lorincz MC, Cimbora DM, et al. Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation. Mol Cell Biol 2000;20:9103-12.
19. Fahrner JA, Eguchi S, Herman JG, Baylin SB. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res 2002;62:7213-8.
20. Stirzaker C, Song JZ, Davidson B, Clark SJ. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res 2004;64:3871-7.
21. Yan PS, Rodriguez FJ, Laux DE, et al. Hypermethylation of ribosomal RNA genes in human breast carcinoma. Br J Cancer 2000;82:514-7.
22. Aerts JL, Christiaens MR, Vandekerckhove P. Evaluation of progesterone receptor expression in eosinophils using real-time quantitative PCR. Biochim Biophys Acta 2002;1571:167-72.
23. Laird PW, Xiong Z. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997;25:2532-4.
24. Cross SH, Charlton JA, Nan X, Bird AP. Purification of CpG islands using a methylated DNA binding column. Nat Genet 1994;6:236-44.
25. Yan PS, Chen CM, Shi H, et al. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res 2001;61:8375-80.
26. Huang TH-M, Perry MR, Laux DE. Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 1999;8:459-70.
27. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (Lond) 2001;411:494-8.
28. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001;15:188-200.
29. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science (Wash DC) 2002;296:550-3.
30. Geiman TM, Robertson KD. Chromatin remodeling, histone modification, and DNA methylation: how does it all fit together? J Cell Biochem 2002;2002:117-25.
31. Orlando V. Polycomb. epigenomes, and control of cell identity. Cell 2003;112:599-606.
32. Satijn DP, Otte AP. Polycomb-group protein complexes: do different complexes regulate distinct targets? Biochim Biophys Acta 1999;1447:1-16.
33. Herman JG, Graff JR, Myohanen S, Nelkin B, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-6.
34. Oesterreich S, Zhang P, Guler RL, et al. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Cancer Res 2001;16:5771-7.
35. Xu X, Murdoch FE, Curran EM, Welshons WV, Fritsch MK. Transcription factor accessibility and histone acetylation of the progesterone receptor gene differs between parental MCF-7 cells and a subline that has lost progesterone receptor expression. Gene (Amst) 2004;17:143-51.
36. Weinmann AS, Yan PS, Oberley MJ, Huang T H-M, Farnham PJ. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev 2002;16:235-44.
37. Shi H, Wei SH, Leu Y-W, et al. Triple analysis of the cancer epigenome: an integrated microarray system for analyzing gene expression, DNA methylation, and histone acetylation. Cancer Res 2003;63:2164-71.
38. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002;99:6567-72.
39. Fujita N, Jaye DL, Kajita M, et al. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 2003;113:207-19.
40. Jackson JP, Lindroth AM, Cao X, Jacobsen SE. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature (Lond) 2002;416:556-60.
41. Tariq M, Saze H, Probst AV, et al. Erasure of CpG methylation in Arabidopsis alters patterns of histone H3 methylation in heterochromatin. Proc Natl Acad Sci USA 2003;100:8823-7.
42. Lynch CA, Tycko B, Bestor TH, Walsh CP. Reactivation of a silenced H19 gene in human rhabdomyosarcoma by demethylation of DNA but not by histone hyperacetylation. Mol Cancer 2002;1:2.
43. Bachman KE, Park BH, Rhee I, et al. Histone modifications and silencing prior to DNA methylation of a tumor supporessor gene. Cancer Cell 2003;3:89-95.
44. Mutskov V, Felsenfeld G. Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J 2004;1:1-12.
45. Jones PA. DNA methylation errors and cancer. Cancer Res 1996;56:2463-7.
46. Pferfer GP, Steigerwald SD, Hansen RS, Gartler SM, Riggs AD. Polymerase chain reaction-aided genomic sequencing of an X chromosome-linked CpG island: methylation patterns suggest clonal inheritance, CpG site autonomy and an explanation of activity state stability. Proc Natl Acad Sci USA 1990;87:8252-6.
47. Feltus FA, Lee EK, Costello JF, Plass C, Vertino PM. Predicting aberrant CpG island methylation. Proc Natl Acad Sci USA 2003;100:12253-8.
48. Costello JF, Fruhwald MC, Smiraglia DJ, et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000;24:132-8.